To Evaluate the Efficacy of Oral Molecular Hydrogen Supplement in Patients With Chronic Diseases
HoHo Biotech
60 participants
May 11, 2024
INTERVENTIONAL
Conditions
Summary
The supplementation of hydrogen molecules as an aid, adjuvant, may speed up recovering the course of the disease. The purpose of this study is to determine the possible efficacy and safety of solid hydrogen supplements for a clinical study in patients with chronic diseases. Patients will receive hydrogen capsules with their conventional treatment for 24 weeks. Investigators will test for any changes in haematologic, urine analysis and health status during and following the exposure period.
Eligibility
Inclusion Criteria4
- Age 20 to 80
- Able to compliant with the protocol
- Able to return to the hospital regularly
- Patients with chronic inflammation, including patients with autoimmune diseases, metabolic-related diseases, chronic kidney disease or nephritis, tumor patients, etc.
Exclusion Criteria3
- Pregnancy
- Expected pregnancy
- Attending other clinical trials with 6 months
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
In experiment group, participants will receive 2 solid hydrogen capsules every day for 24 weeks. In control group, participants will receive 2 capsules not containing hydrogen every day for 24 weeks.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06401785